Smith CL - Search Results

1

HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes.

Nikolai BC, Lanz RB, York B, Dasgupta S, Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM, Smith CL, O'Malley BW. Nikolai BC, et al. Among authors: smith cl. Cancer Res. 2016 Mar 15;76(6):1463-75. doi: 10.1158/0008-5472.CAN-15-2383. Epub 2016 Feb 1. Cancer Res. 2016. PMID: 26833126 Free PMC article.

2

Transcriptional regulation by steroid receptor coactivator phosphorylation.

Wu RC, Smith CL, O'Malley BW. Wu RC, et al. Among authors: smith cl. Endocr Rev. 2005 May;26(3):393-9. doi: 10.1210/er.2004-0018. Epub 2005 Apr 6. Endocr Rev. 2005. PMID: 15814849 Review.

3

SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity.

Coleman KM, Lam V, Jaber BM, Lanz RB, Smith CL. Coleman KM, et al. Among authors: smith cl. Biochem Biophys Res Commun. 2004 Oct 8;323(1):332-8. doi: 10.1016/j.bbrc.2004.08.090. Biochem Biophys Res Commun. 2004. PMID: 15351741

4

Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.

Zheng FF, Wu RC, Smith CL, O'Malley BW. Zheng FF, et al. Among authors: smith cl. Mol Cell Biol. 2005 Sep;25(18):8273-84. doi: 10.1128/MCB.25.18.8273-8284.2005. Mol Cell Biol. 2005. PMID: 16135815 Free PMC article.

5

Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.

Smith CL, Migliaccio I, Chaubal V, Wu MF, Pace MC, Hartmaier R, Jiang S, Edwards DP, Gutiérrez MC, Hilsenbeck SG, Oesterreich S. Smith CL, et al. Breast Cancer Res Treat. 2012 Nov;136(1):253-65. doi: 10.1007/s10549-012-2262-7. Epub 2012 Sep 27. Breast Cancer Res Treat. 2012. PMID: 23015261 Free PMC article.

6

Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.

Cavarretta IT, Mukopadhyay R, Lonard DM, Cowsert LM, Bennett CF, O'Malley BW, Smith CL. Cavarretta IT, et al. Among authors: smith cl. Mol Endocrinol. 2002 Feb;16(2):253-70. doi: 10.1210/mend.16.2.0770. Mol Endocrinol. 2002. PMID: 11818499

7

Coregulator function: a key to understanding tissue specificity of selective receptor modulators.

Smith CL, O'Malley BW. Smith CL, et al. Endocr Rev. 2004 Feb;25(1):45-71. doi: 10.1210/er.2003-0023. Endocr Rev. 2004. PMID: 14769827 Review.

8

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

Lonard DM, Nawaz Z, Smith CL, O'Malley BW. Lonard DM, et al. Among authors: smith cl. Mol Cell. 2000 Jun;5(6):939-48. doi: 10.1016/s1097-2765(00)80259-2. Mol Cell. 2000. PMID: 10911988 Free article.

9

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

Smith CL, Nawaz Z, O'Malley BW. Smith CL, et al. Mol Endocrinol. 1997 Jun;11(6):657-66. doi: 10.1210/mend.11.6.0009. Mol Endocrinol. 1997. PMID: 9171229

10

Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.

Lonard DM, Smith CL. Lonard DM, et al. Among authors: smith cl. Steroids. 2002 Jan;67(1):15-24. doi: 10.1016/s0039-128x(01)00133-7. Steroids. 2002. PMID: 11728517 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,096 results

Search Page

Filters